Its beneficial effect on hepatic fibrosis may be due to its inhibition of pro-inflammatory cytokines such as IL-6 and TNF-α in the liver (Chehrehgosha et al. 2021); however, the other mechanisms involved in reducing hepatic fibrosis by EMPA remain unclear. The gene discussed is IL6; the disease is Hepatic fibrosis.